Harmony Biosciences (HRMY) Tops Q1 EPS by 18c
Tweet
Share
E-mail
Get Alerts HRMY Hot Sheet
Join SI Premium – FREE
(Updated - May 2, 2023 7:41 AM EDT)
Harmony Biosciences (NASDAQ: HRMY) reported Q1 EPS of $0.66, $0.18 better than the analyst estimate of $0.48. Revenue for the quarter came in at $119.13 million versus the consensus estimate of $120.61 million.
For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Independent Bank receives regulatory approval for HCB Financial acquisition
- H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
